Pau D'Arco

Wadatacce

• Evidencearancin shaida don kimanta inganci don ...
• Kariya & Gargaɗi na Musamman:

Pau d’arco itace da ke girma a dajin Amazon da sauran yankuna masu zafi na Kudanci da Amurka ta Tsakiya. Itacen Pau d’arco yana da yawa kuma yana tsayayya da ruɓewa. Sunan "pau d'arco" na Fotigal ne don "baka mai baka," kalma ce da ta dace idan aka yi la’akari da yadda ‘yan asalin Kudancin Amurka ke amfani da itacen don yin bakunan farauta. Bawo da itacen ana amfani da su wajen yin magani.

Mutane suna amfani da pau d’arco don yanayi kamar kamuwa da cuta, ciwon daji, ciwon sukari, gyambon ciki, da wasu da yawa, amma babu wata kyakkyawar shaidar kimiyya da zata goyi bayan waɗannan amfani. Yin amfani da pau d’arco na iya zama mara lafiya, musamman a manyan allurai.

Ana samun samfuran kasuwanci waɗanda ke ƙunshe da pau d’arco a cikin kwantena, ƙaramin abu, cirewa, foda, da kuma nau'in shayi. Amma wani lokacin yana da wuya a san abin da ke cikin kayan pau d’arco. Wasu nazarin sun nuna cewa wasu kayayyakin pau d’arco da aka sayar a Kanada, Brazil, da Portugal ba su ƙunshe da abubuwan da ke aiki cikin adadin daidai.

Magunguna na Compwararren Bayanan Bayanai ƙimar tasiri bisa ga shaidar kimiyya bisa ga mizani mai zuwa: Inganci, Mai yuwuwa Mai Yiwuwa, Yiwuwar Tasiri, Yiwuwar Mara Inganci, Mai yiwuwa Mara Inganci, Mara Inganci, da suarancin Shaida don Rate.

Effectivenessimar tasiri don PAU D’ARCO sune kamar haka:

Evidencearancin shaida don kimanta inganci don ...

• Anemia.
• Arthritis-kamar zafi.
• Asthma.
• Bladder da cututtukan prostate.
• Tafasa.
• Bronchitis.
• Ciwon daji.
• Ciwon sanyi.
• Ciwon suga.
• Gudawa.
• Cancanta.
• Fibromyalgia.
• Mura.
• Cututtuka tare da yisti, ƙwayoyin cuta, ƙwayoyin cuta, ko ƙwayoyin cuta.
• Tsutsar ciki.
• Matsalar hanta.
• Psoriasis.
• Cututtukan da ake dauka ta hanyar jima'i (gonorrhea, syphilis).
• Matsalolin ciki.
• Sauran yanayi.

Ana buƙatar ƙarin shaida don kimanta tasirin pau d’arco don waɗannan amfani.

Binciken farko ya nuna cewa pau d’arco na iya hana ƙwayoyin cutar kansa girma. Hakanan yana iya jinkirin haɓakar tumo ta hana ƙari daga haɓaka hanyoyin jini da ake buƙata. Koyaya, allurai da ake buƙata don haifar da cututtukan ƙwayar cuta suna haifar da mummunan sakamako a cikin mutane.

Pau d’arco ne YIWU KA KIYAYE lokacin da aka sha ta baki. A cikin manyan allurai, pau d’arco na iya haifar da tsananin tashin zuciya, amai, gudawa, jiri, da zubar jini na ciki. Ba a san amincin pau d’arco a cikin ƙananan allurai ba.

Kariya & Gargaɗi na Musamman:

Ciki da shan nono: Yayin daukar ciki, pau d’arco shine YIWU KA KIYAYE lokacin da aka ɗauke ta baki a cikin adadin kuɗi, kuma KIMA INSAFE a cikin manyan allurai. Ba a san isa game da amincin shafa shi zuwa fata ba. Tsaya kan gefen aminci kuma ku guji amfani idan kuna da ciki.

Babu wadataccen ingantaccen bayani game da lafiyar shan pau d’arco idan kuna shan nono. Kasance a gefen aminci ka guji amfani.

Tiyata: Pau d’arco na iya yin jinkirin daskarewar jini kuma zai iya kara damar zuban jini yayin da bayan tiyata. Dakatar da amfani da shi aƙalla makonni 2 kafin fara aikin tiyata.

Matsakaici

Yi hankali da wannan haɗin.

Magunguna waɗanda ke jinkirta daskarewar jini (Magungunan Anticoagulant / Antiplatelet)

Pau d’arco na iya jinkirta daskarewar jini. Shan pau d’arco tare da magunguna wadanda suma jinkirin daskarewa na iya kara damar samun rauni da zubar jini.

Wasu magungunan da ke rage daskarewar jini sun hada da asfirin, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, wasu), ibuprofen (Advil, Motrin, wasu), naproxen (Anaprox, Naprosyn, wasu), dalteparin (Fragmin), enoxaparin (Lovenox) , heparin, warfarin (Coumadin), da sauransu.

Ganye da kari wadanda zasu iya rage daskarewar jini

Pau d’arco na iya yin jinkirin daskarewar jini. Shan pau d’arco tare da wasu ganyayyaki ko kari wanda kuma jinkirin daskarewa na iya kara damar bruyn da zubar jini a wasu mutane. Wadannan ganyayyaki sun hada da alfalfa, Angelica, clove, danshen, kirjin kirji, jan kabeji, turmeric, da sauransu.

Babu sanannun hulɗa da abinci.

Halin da ya dace na pau d’arco ya dogara da dalilai da yawa kamar su shekarun mai amfani, lafiya, da sauran yanayi da yawa. A wannan lokacin babu isasshen bayanan kimiyya don ƙayyade madaidaicin ƙididdigar maganin pau d’arco. Ka tuna cewa kayan halitta ba koyaushe suna da aminci ba kuma ƙididdigar na iya zama mahimmanci. Tabbatar da bin kwatancen dacewa akan alamun samfuran kuma tuntuɓi likitan ku ko likita ko wasu ƙwararrun likitocin kiwon lafiya kafin amfani.

Ébénier de Guyane, Ébène Vert, Handroanthus impetiginosus, Ipe, Ipe Roxo, Ipes, Lapacho, Lapacho Colorado, Lapacho Morado, Lapacho Negro, Lébène, Pink Trumpet Tree, Purple Lapacho, Quebracho, Red Lapacholap, Tabe, Tabe , Tabebuia palmeri, Taheebo, Taheebo Tea, Tecoma impetiginosa, Thé Taheebo, Trumpet Bush.

Don ƙarin koyo game da yadda aka rubuta wannan labarin, da fatan za a duba Magunguna na Compwararren Bayanan Bayanai hanya.

1. Algranti E, Mendonça EM, Ali SA, Kokron CM, Raile V. Asma na aiki wanda Ipe (Tabebuia spp) ya haifar. J Bincike Allergol Clin Immunol 2005; 15: 81-3. Duba m.
2. Zhang L, Hasegawa I, Ohta T. Abubuwan da ke haifar da anti-inflammatory cyclopentene daga haushi na ciki na Tabebuia avellanedae. Fitoterapia 2016; 109: 217-23. Duba m.
3. Lee S, Kim IS, Kwak TH, Yoo HH. Nazarin maganin metabolism na kwatancen ß-lapachone a cikin linzamin kwamfuta, bera, kare, biri, da hanta ɗan adam microsomes ta amfani da ruwa chromatography-tandem taro spectrometry. J Maganin Biomed Anal 2013; 83: 286-92. Duba m.
4. Hussain H, Krohn K, Ahmad VU, et al. Lapachol: bayyani. Arkivok 2007 (ii): 145-71.
5. Pereira IT, Burci LM, da Silva LM, et al. Sakamakon antiulcer na cirewar haushi na Tabebuia avellanedae: kunna ƙwayoyin ƙwayoyin cuta a cikin ƙwayar mucosa na ciki yayin aikin warkarwa. Yanayin Yanayin 2013; 27: 1067-73. Duba m.
6. Macedo L, Fernandes T, Silveira L, et al. Ayyukan ß-Lapachone a cikin aiki tare da magungunan ƙwayoyin cuta na yau da kullun game da ƙwayoyin Staphylococcus aureus na methicillin masu ƙarfi. Maganin Phytomedicine 2013; 21: 25-9. Duba m.
7. Pires TC, Dias MI, Calhelha RC, et al. Abubuwan da ke tattare da kwayar halitta na Tabebuia da ke tattare da yanayin halittar jiki da kuma tsarin halittar jiki: kwatankwacin abubuwan ci da karin abincin. Kwayoyin Halitta 2015; 1; 20: 22863-71. Duba m.
8. Awang DVC. Taheebo na kasuwanci bashi da sinadarin aiki. Harafin Bayanai na 726 Can Pharm J. 1991; 121: 323-26.
9. Awang DVC, Dawson BA, Ethier JC, et al. Naphthoquinone Maɗaukakan Kasuwancin Lapacho / Pau d’arco / Taheebo. J Ganye Spic Med Shuke-shuke. 1995; 2: 27-43.
10. Nepomuceno JC. Lapachol da dangoginsa azaman kwayoyi don maganin cutar kansa. A cikin: Shuke-shuke da Amfanin gona - Binciken Halittu da Kimiyyar Fasaha, 1st ed. iConcept Press Ltd .. An dawo daga: https://www.researchgate.net/profile/Julio_Nepomuceno/publication/268378689_Lapachol_and_its_derivatives_as_potential_drugs_for_cancer_treatment/links/5469c8640cf20dedafd1031.
11. Kudin JB, Morais VM, Lima CR. Resistência natural de nove madeiras yi semi-árido brasileiro a fungos causadores da podridão-mole. R. Árvore, 2005; 29: 365-71.
12. Kreher B, Lotter H, Cordell GA, Wagner H. New Furanonaphthoquinones da sauran Mazhabobin Tabebuia avellanedae da Ayyukansu na Immunomodulating in vitro. Planta Med. 1988; 54: 562-3. Duba m.
13. de Almeida ER, da Silva Filho AA, dos Santos ER, Lopes CA. Ayyukan antiinflammatory na lapachol. J Ethnopharmacol. 1990; 29: 239-41. Duba m.
14. Guiraud P, Steiman R, Campos-Takaki GM, Seigle-Murandi F, Simeon de Buochberg M. Kwatanta ayyukan antibacterial da antifungal na lapachol da beta-lapachone. Planta Med. 1994; 60: 373-4. Duba m.
15. Toshe JB, Serpick AA, Miller W, Wiernik PH. Nazarin asibiti na farko tare da lapachol (NSC-11905). Cancer Cutar Canji Rep 2. 1974; 4: 27-8. Duba m.
16. Kung, H. N., Yang, M. J., Chang, C. F., Chau, Y. P., da Lu, K. S. In vitro kuma a cikin vivo rauni-inganta ayyukan beta-lapachone. Am. J Physiol Cell din Physiol 2008; 295: C931-C943. Duba m.
17. Byeon, S. E., Chung, J. Y., Lee, Y. G., Kim, B. H., Kim, K. H., da Cho, J. Y. In vitro kuma a cikin vivo anti-inflammatory effects na taheebo, wani ruwa cire daga cikin haushi na ciki na Tabebuia avellanedae. J Ethnopharmacol. 9-2-2008; 119: 145-152. Duba m.
18. Twardowschy, A., Freitas, CS, Baggio, CH, Mayer, B., dos Santos, AC, Pizzolatti, MG, Zacarias, AA, dos Santos, EP, Otuki, MF, da Marques, MC Antiulcerogenic aiki na cire haushi Tabebuia avellanedae, Lorentz tsohon Griseb. J Ethnopharmacol. 8-13-2008; 118: 455-459. Duba m.
19. Queiroz, ML, Valadares, MC, Torello, CO, Ramos, AL, Oliveira, AB, Rocha, FD, Arruda, VA, da Accorci, WR Nazarin kwatancen tasirin Tabebuia avellanedae haushi cirewa da beta-lapachone akan amsar hematopoietic beraye masu ɗauke da ƙari. J Ethnopharmacol. 5-8-2008; 117: 228-235. Duba m.
20. Savage, RE, Tyler, AN, Miao, XS, da Chan, TC Gano sabon littafin glucosylsulfate conjugate a matsayin mai cike da cigaban 3,4-dihydro-2,2-dimethyl-2H-naphtho [1,2-b] pyran- 5,6-dione (ARQ 501, beta-lapachone) a cikin dabbobi masu shayarwa. Magungunan ƙwayoyi na Metab. 2008; 36: 753-758. Duba m.
21. Yamashita, M., Kaneko, M., Iida, A., Tokuda, H., da Nishimura, K. Kirkirar aiki mai tsafta da kuma cytotoxicity na kansar chemopreventive naphthoquinone daga Tabebuia avellanedae. Bioorg.Med Chem.Lett. 12-1-2007; 17: 6417-6420. Duba m.
22. Kim, S. O., Kwon, J. I., Jeong, Y. K., Kim, G. Y., Kim, N., da Choi, Y. H. uaddamar da Egr-1 yana haɗuwa da anti-metastatic da anti-invasive ikon beta-lapachone a cikin ƙwayoyin hepatocarcinoma na ɗan adam. Biosci Biotechnol Biochem 2007; 71: 2169-2176. Duba m.
23. de Cassia da Silveira E Sa da de Oliveira, Guerra M. Cutar haifuwa ta lapachol a cikin manyan berayen Wistar da aka miƙa wa magani na gajeren lokaci. Mai kulawa.Res. 2007; 21: 658-662. Duba m.
24. Kung, H. N., Chien, C. L., Chau, G. Y., Don, M. J., Lu, K. S., da Chau, Y. P. Shigar da siginar NO / cGMP a cikin apoptotic da anti-angiogenic sakamakon beta-lapachone akan ƙwayoyin endothelial a cikin vitro. J Jiki Physiol 2007; 211: 522-532. Duba m.
25. Woo, HJ, Park, KY, Rhu, CH, Lee, WH, Choi, BT, Kim, GY, Park, YM, da Choi, YH Beta-lapachone, quinone da aka ware daga Tabebuia avellanedae, yana haifar da apoptosis a cikin layin hepoma hepoma HepG2 ta hanyar shigar da Bax da kunnawa na akwatin gawa. J Abincin 2006; 9: 161-168. Duba m.
26. Son, DJ, Lim, Y., Park, YH, Chang, SK, Yun, YP, Hong, JT, Takeoka, GR, Lee, KG, Lee, SE, Kim, MR, Kim, JH, da Park, Inhibitory BS sakamakon Tabebuia impetiginosa cire haushi na ciki akan tara platelet da yaduwar kwayar tsoka mai santsi ta hanyan danniyar arachidonic acid da ERK1 / 2 MAPK kunnawa. J Ethnopharmacol. 11-3-2006; 108: 148-151. Duba m.
27. Lee, JI, Choi, DY, Chung, HS, Seo, HG, Woo, HJ, Choi, BT, da Choi, YH beta-lapachone yana haifar da hana girma da apoptosis a cikin ƙwayoyin kansar mafitsara ta hanyar sauya gidan Bcl-2 da kunnawa makabartu. Exp.Oncol. 2006; 28: 30-35. Duba m.
28. Pereira, EM, Machado, Tde B., Leal, IC, Jesus, DM, Damaso, CR, Pinto, AV, Giambiagi-deMarval, M., Kuster, RM, da Santos, KR Tabebuia avellanedae naphthoquinones: ayyukan da ke kan ƙarfin methicillin staphylococcal damuwa, aikin cytotoxic kuma a cikin vivo dermal irritability analysis. Ann.Clin.Microbiol. Antimicrob. 2006; 5: 5. Duba m.
29. Felicio, A. C., Chang, C. V., Brandao, M. A., Peters, V. M., da Guerra, Mde O. Ci gaban haihuwa a cikin berayen da aka kula da su tare da lapachol. Hana haihuwa 2002; 66: 289-293. Duba m.
30. Guerra, Mde O., Mazoni, A. S., Brandao, M. A., da Peters, V. M. Toxicology na Lapachol a cikin berayen: embryolethality. Braz.J Biol. 2001; 61: 171-174. Duba m.
31. Lemos OA, Sanches JC, Silva IE, et al. Tasirin Genotoxic na tasirin Tabebuia impetiginosa (Mart. Ex DC.) Standl. (Lamiales, Bignoniaceae) cirewa a cikin berayen Wistar. Halitta Mol Biol 2012; 35: 498-502. Duba m.
32. Kiage-Mokua BN, Roos N, Schrezenmeir J. Lapacho Tea (Tabebuia impetiginosa) Cire Cutar hana Pancreatic Lipase da Jinkirta para Triglyceride para Rats. Phytother Res 2012 Mar 17. doi: 10.1002 / ptr.4659. Duba m.
33. de Melo JG, Santos AG, de Amorim EL, et al. Shuke-shuke na magani da aka yi amfani da su azaman wakilan antitumor a cikin Brazil: hanyar ɗabi'a ce. Basedarin Maɗaukaki Comarin Maɗaukaki Med 2011; 2011: 365359. Epub 2011 Mar 8. Duba m.
34. Gómez Castellanos JR, Prieto JM, Heinrich M. Red Lapacho (Tabebuia impetiginosa) - kayan masarufin ilimin ɗan adam na duniya? J Jumlar 2009; 121: 1-13. Duba m.
35. Park BS, Lee HK, Lee SE, da sauransu. Ayyukan antibacterial na Tabebuia impetiginosa Martius tsohon DC (Taheebo) akan Helicobacter pylori. J Zuciya 2006; 105: 255-62. Duba m.
36. Park BS, Kim JR, Lee SE, et al. Abubuwan da ke tattare da haɓakar haɓakar mahaɗan da aka gano a cikin Tabebuia impetiginosa haushi na ciki akan ƙwayoyin cuta na hanji ɗan adam. J aikin abinci Chem 2005; 53: 1152-7. Duba m.
37. Koyama J, Morita I, Tagahara K, Hirai K. Cyclopentene dialdehydes daga Tabebuia impetiginosa. Phytochemistry 2000; 53: 869-72. Duba m.
38. Park BS, Lee KG, Shibamoto T, et al. Ayyukan antioxidant da halayyar ma'abota tashin hankali na Taheebo (Tabebuia impetiginosa Martius ex DC). J Agric Abincin Chem 2003; 51: 295-300. Duba m.

An sake dubawa - 08/16/2018